Bell Therapeutics Unveils Innovative Treatment for Insomnia
Seoul, Monday, 23 June 2025.
On June 23, Korean firm Bell Therapeutics introduced ‘Sleep Thera,’ a digital medical device for insomnia, aiming for faster and more effective results while meeting regulatory standards.
Innovative Approach to Insomnia Treatment
Bell Therapeutics, a Korean digital healthcare company with a strong foundation in brain science, has announced the launch of ‘Sleep Thera’, an innovative digital therapeutic aimed at combating insomnia. The announcement came on June 23, 2025, marking a significant advancement in digital health solutions, particularly in the treatment of sleep disorders. With Sleep Thera gaining ‘Innovative Medical Device’ status from Korea’s Ministry of Food and Drug Safety, it positions itself as a priority candidate for market entry, where it will be available for 3 to 5 years in medical settings on a non-reimbursed basis [1].
Technology-Driven Solutions in Sleep Health
Sleep Thera offers a novel approach by utilizing personalized digital stimuli based on biometric signals, claiming to improve sleep quality more efficiently than existing treatments. This innovative use of technology in healthcare exemplifies how digital platforms can play a pivotal role in addressing mental health disorders such as insomnia [1]. By presenting its clinical results at the American Sleep Association Meeting, the device has garnered international attention, further establishing Bell Therapeutics as a leader in digital health innovation [1].
Clinical Effectiveness and Future Prospects
The unveiling of ‘Sleep Thera’ underscores the growing need for effective medical interventions addressing the increasing prevalence of sleep disorders, which affect a substantial portion of the global population. The device’s development, steeped in scientific research and clinical evaluations, highlights a trend toward integrating digital solutions in traditional healthcare practices [2]. With an emphasis on leveraging brain science, Sleep Thera aims to deliver accessible solutions that could potentially revolutionize insomnia treatment [2].